Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Roth

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Journal of the American Society of Nephrology : JASN|April 21, 2016
Hepatitis C Virus Infection in Chronic Kidney DiseaseMarco Ladino, Fernando Pedraza, David Roth
Kidney360|April 4, 2022
Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?Javier Pagan, Marco Ladino, David Roth
Seminars in Dialysis|November 27, 2018
Treating hepatitis C virus in dialysis patients: How, when, and why?Javier Pagan, Marco Ladino, David Roth
Revue Medicale Suisse|November 20, 2025
[Hematochezia : when should we worry ?]David Roth, Rasa Kontrauskaite, Agnes Puigrenier
Kidney International Reports|April 14, 2020
Kidney Transplantation From a Hepatitis C Virus-Infected Donor Into an Uninfected Recipient: Ready for Prime Time?Javier Pagan, Marco Ladino, David Roth
Journal of Nephrology|January 22, 2004
Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulinDebasish Banerjee, Warren Kupin, David Roth
World Journal of Hepatology|July 26, 2017
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney diseaseMarco Ladino, Fernando Pedraza, David Roth
Clinical Liver Disease|May 2, 2019
Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus-infected patients with chronic kidney disease and end-stage renal diseaseFernando Pedraza, Marco Ladino, David Roth
Clinical Pharmacokinetics|September 10, 2017
Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus ErythematosusHerbert Struemper, Mita Thapar, David Roth
Physical Review. E|April 18, 2026
Modeling tariff-induced network failure and hysteresisDavid Roth, Amir Bashan, Sergey V Buldyrev
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Journal of the American Society of Nephrology : JASN|April 21, 2016
Hepatitis C Virus Infection in Chronic Kidney DiseaseMarco Ladino, Fernando Pedraza, David Roth
Kidney360|April 4, 2022
Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?Javier Pagan, Marco Ladino, David Roth
Seminars in Dialysis|November 27, 2018
Treating hepatitis C virus in dialysis patients: How, when, and why?Javier Pagan, Marco Ladino, David Roth
Revue Medicale Suisse|November 20, 2025
[Hematochezia : when should we worry ?]David Roth, Rasa Kontrauskaite, Agnes Puigrenier
Kidney International Reports|April 14, 2020
Kidney Transplantation From a Hepatitis C Virus-Infected Donor Into an Uninfected Recipient: Ready for Prime Time?Javier Pagan, Marco Ladino, David Roth
Journal of Nephrology|January 22, 2004
Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulinDebasish Banerjee, Warren Kupin, David Roth
World Journal of Hepatology|July 26, 2017
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney diseaseMarco Ladino, Fernando Pedraza, David Roth
Clinical Liver Disease|May 2, 2019
Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus-infected patients with chronic kidney disease and end-stage renal diseaseFernando Pedraza, Marco Ladino, David Roth
Clinical Pharmacokinetics|September 10, 2017
Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus ErythematosusHerbert Struemper, Mita Thapar, David Roth
Physical Review. E|April 18, 2026
Modeling tariff-induced network failure and hysteresisDavid Roth, Amir Bashan, Sergey V Buldyrev
Pageof 16